ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,748,101, issued on Sept. 29, was assigned to THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, N.H.).

"Composition and method for inhibiting BORC complex to treat cancers with NF1 deficiency and dysregulated RAS signaling" was invented by Yolanda Sanchez (Orford, N.H.) and Stephanie Joy Bouley (North Smithfield, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and compositions useful for identification of potential therapeutic agents for the treatment of a NF1- or RAS-associated disorder. Disclosed herein are also methods and compositions useful for the treatment of a NF1- or RAS-associated disorder."

The patent was filed on ...